- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo "GeparDouze"
This study looks at new ways to treat early triple-negative breast cancer. It combines standard chemotherapy with a newer drug, Atezolizumab (or a dummy drug), to see if it can stop the cancer from coming back. It's a large study, comparing different treatment approaches.
For: Patients with early breast cancerGermany · Spain - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Metastatic Non-Small Cell Lung Cancer (Morpheus-Lung)
This study is testing different combinations of treatments for advanced lung cancer. It's looking to see how well these new drug combinations work and if they are safe. The aim is to find better ways to treat non-small cell lung cancer that has spread.
For: Metastatic non-small cell lung cancer (NSCLC)France · Spain